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In this paper, we describe and evaluate a new distributed architecture for clinical decision support called
SANDS (Service-oriented Architecture for NHIN Decision Support), which leverages current health infor-
mation exchange efforts and is based on the principles of a service-oriented architecture. The architecture
allows disparate clinical information systems and clinical decision support systems to be seamlessly inte-
grated over a network according to a set of interfaces and protocols described in this paper. The architec-
ture described is fully deﬁned and developed, and six use cases have been developed and tested using a
prototype electronic health record which links to one of the existing prototype National Health Informa-
tion Networks (NHIN): drug interaction checking, syndromic surveillance, diagnostic decision support,
inappropriate prescribing in older adults, information at the point of care and a simple personal health
record. Some of these use cases utilize existing decision support systems, which are either commercially
or freely available at present, and developed outside of the SANDS project, while other use cases are based
on decision support systems developed speciﬁcally for the project. Open source code for many of these
components is available, and an open source reference parser is also available for comparison and testing
of other clinical information systems and clinical decision support systems that wish to implement the
SANDS architecture.
The SANDS architecture for decision support has several signiﬁcant advantages over other architectures
for clinical decision support. The most salient of these are:
1. Greater modularity than other architectures, allowing for work to be distributed.
2. The potential for creating and sustaining a commercial market for clinical decision support.
3. Reduced cost and risk of trying new decision support systems because of its ability to easily integrate a
variety of decision support services, and to easily remove them, if desired, as well.
4. Signiﬁcant freedom for developers of clinical decision support systems to choose the way they repre-
sent knowledge and internally implement their system, in comparison to other approaches which
constrain such developers to a particular knowledge representation formalism.
5. Uniﬁcation of the direction and agenda of decision support research and development with promising
near-term efforts to improve interoperability of clinical systems.
 2008 Elsevier Inc. All rights reserved.1. Introduction
Myriad studies have shown that clinical decision support can
reduce medical errors and improve healthcare quality in both inpa-ll rights reserved.
aining Grant 1T15LM009461.
neral Medicine, Brigham &
Tremont Street, Third Floor,
).tient and ambulatory settings [1,2]. However, only a small number
of sites (generally academic medical centers and large integrated
delivery networks) make signiﬁcant use of the most advanced
and effective decision support interventions [3]. This lack of
wide-spread use stems from a variety of causes, ranging from tech-
nical to political to economic; however, perhaps the main cause is
resources: academic medical centers and integrated delivery net-
works are more likely to have the time, money, and experience re-
quired to design, develop, and implement such systems.
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ing—having the successful sites share their content with the rest of
the hospitals and providers. In fact, medical informatics has
worked on a variety of approaches for sharing content, starting
with Arden Syntax in 1989 [4,5]. However, to this day, none of
these content sharing systems have seen signiﬁcant adoption and
many have never made it out of the lab.
In this paper, we introduce a new approach to sharing decision
support content which leverages existing work towards developing
a National Health Information Network (NHIN). We call this ap-
proach SANDS: a Service-oriented Architecture for NHIN Decision
Support. SANDS differs signiﬁcantly from prior approaches to shar-
ing clinical content. These prior approaches generally involved
developing a lingua franca for encoding clinical knowledge. How-
ever, because clinical knowledge is diverse and complex, and not
always easy to represent in a single standardized format (e.g., if-
then rules or Bayesian logic), such approaches necessarily con-
strain the scope and type of clinical knowledge which can be rep-
resented. SANDS, by contrast, deﬁnes a set of interfaces that a
decision support service should make available, but leaves the
choice of knowledge representation up to the implementer.
This paper follows a paper we presented at the American Med-
ical Informatics Association (AMIA) Annual Symposium in 2007.
There, we presented an overview of the SANDS architecture as well
as some early timing data. This paper signiﬁcantly expands the
description of the SANDS architecture, includes substantially more
timing data and adds three additional modes of evaluation [6].
2. Hypothesis
SANDS is designed to surmount the limitations of existing
architectures described in the previous section. It is hypothesized
that SANDS can provide signiﬁcant advantages over existing deci-
sion support architectures in the areas of transferability, scalability
and integrability, deﬁned as:
Transferability: The ability to take a known-successful interven-
tion in operation at one site and transfer it to another site.
Scalability: The ability to provide a wide variety of kinds of deci-
sion support (such as patient level alerts and reminders, infor-
mation interventions, panel or population-wide interventions,
patient-oriented decision support, etc.) within a given
architecture.
Integrability: The ability to readily integrate a decision support
system into a clinical system. This covers issues such as proper
terminology and data-ﬁeld mapping as well as issues like sup-
portability and maintainability of knowledge content.
The purpose of this paper is to describe the SANDS architecture,
as well as a working prototype of the architecture we have
developed.3. Overview of the architecture
SANDS is a service-oriented architecture for clinical decision
support involving clinical systems (which are the clients of
SANDS), services that provide patient data (such as an NHIN) and
services which make clinical decision support inferences. SANDS
differs from previous efforts because it places layers of abstraction
in front of both the clinical decision support services (CDS) and the
clinical information system (CIS). Moreover, this architecture
explicitly contemplates the case where a patient’s record is spread
across multiple clinical systems and the parallel case where several
disparate clinical decision support systems are needed to fully in-form a decision. The case where a patient’s record is spread across
several systems and needs to be reassembled to provide a com-
plete clinical picture is the exact case that efforts to create a Na-
tional Health Information Network (NHIN) are targeting and, as
such, the patient data half of the architecture will draw heavily
on existing developments in the NHIN space.
On the decision support network side, one could imagine a case
where a physician would like to query several different decision
support service providers for different kinds of decision support
for a given patient. For example, if the physician were prescribing
a new drug to a diabetic patient, he or she might want to query a
guideline service provided by the American Diabetes Association
for the latest guidelines in diabetes management [7], and might
also want to send the proposed prescription to a drug-interaction
checking service such as the one provided by Thomson Microme-
dex (Thomson Corporation, Denver, CO). This architecture also
explicitly allows for the case where one decision support system
queries another—for example, the American Diabetes Association
might develop a decision support module for evidence-based dia-
betic care, and that module may in turn depend on another mod-
ule, provided by the American Heart Association, that deﬁnes
hypertension.
3.1. An example use case
To fully understand this architecture, it is perhaps best to oper-
ationalize it. Consider a case with two care providers: Dr. Ander-
son, a primary care provider, who uses Epic’s EHR (Epic Systems
Corporation, Madison, WI); and Dr. Baxter, a gastroenterologist
who uses the Logician EHR (now called the Centricity Physician Of-
ﬁce EHR [GE Healthcare, Waukesha, WI]). They share a common
patient in Frank Jones. Mr. Jones sees Dr. Baxter for management
of severe Gastroesophageal Reﬂux Disease (GERD), but today pre-
sents to his primary care provider, Dr. Anderson, complaining of
a sore throat, which Dr. Anderson diagnoses as streptococcal phar-
yngitis. Dr. Anderson plans to prescribe erythromycin to treat the
infection, but ﬁrst asks Mr. Jones what medications he’s on.
Mr. Jones reports that he is taking Lipitor and Aspirin, as prescribed
by Dr. Anderson, as well as Prevacid for his GERD, as prescribed by
Dr. Baxter. Seeing no danger, Dr. Anderson initiates a prescription
for erythromycin in her clinical system, but before the prescription
is accepted, the decision support network is queried. A message,
containing the intended prescription, as well as a pointer to
Mr. Jones’ record in the NHIN is sent to a drug checking service that
Dr. Anderson subscribes to. This service sends a medication list
query to the NHIN interface which uses its record locator service
to ﬁnd that Mr. Jones has records in two disparate clinical systems:
those of Drs. Anderson and Baxter. The NHIN interface requests the
medication lists in these systems, aggregates them and returns
them to the drug checking service. This service notices, however,
that Dr. Baxter’s medication list indicates that Mr. Jones is actually
on Propulsid for his GERD, not Prevacid, as Mr. Jones had indicated
to Dr. Anderson. There is a very severe and potentially fatal inter-
action between Propulsid and Erythromycin, and the system pro-
vides this information to Dr. Anderson’s clinical system which
raises an alert and blocks the prescription. Although this may seem
like a simple case, it’s important to note that, even though the FDA
engaged in a signiﬁcant outreach and public relations campaign to
make doctors aware of this interaction it was responsible for a sig-
niﬁcant number of fatalities [8,9]. In the end, the FDA had to with-
draw Propulsid from the market because it was unable to reliably
prevent the two drugs from being co-prescribed. A decision sup-
port architecture such as the one described herein (or another
safety mechanism, such as pharmacist veriﬁcation) may be neces-
sary to reduce the risk of certain drugs to a level that would justify
keeping them on the market.
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This example highlights several key points about the SANDS
architecture. First, the architecture is deﬁned entirely by inter-
faces. There are no restrictions on the internal knowledge repre-
sentation approach taken by the decision support components,
and there are no restrictions on the way that the clinical systems
store clinical data internally. As long as the systems export the
appropriate interfaces, they are compliant with the requirements
of this architecture. This interface-driven approach is sometimes
generically called a Service Oriented Architecture (SOA). SOAs
are currently making signiﬁcant inroads in the healthcare IT
space. Kaiser Permanente [10], MD Anderson Cancer Center
[11], the Mayo Clinic [10] and the Partners Healthcare System
[12] have all announced plans to migrate their clinical systems
to an SOA. None, however, has yet announced plans to fully mi-
grate their decision support to an SOA, largely because there is
no clear architecture over which to do so. This paper aims to ﬁll
that gap.
3.3. The role of standards
Building an SOA for decision support requires a signiﬁcant
number of standards. These standards fall roughly into two
groups: healthcare informatics standards, such as Health Level
7 (HL7) [13–16], the Systematized Nomenclature of Medicine
SNOMED [17], National Council for Prescription Drug Programs
(NCPDP) SCRIPT [16], RxNorm [18,19] and National Drug Codes
(NDC) [20,21] which might be used to describe drugs, or transfer
patient data; and SOA-related standards, such as the Simple Ob-
ject Access Protocol (SOAP) and Extensible Markup Language
(XML), which are used to transport data between services, and
the Universal Description, Discovery, and Integration language
(UDDI) and the Web Service Deﬁnition Language (WSDL), which
are used for discovery of services, and interface deﬁnition.
Depending on the application domain, other standards may also
be required. Standards are not a major focus of this paper, in
large part because robust standards harmonization activities
coordinated by the ANSI Healthcare Information Technology
Standards Panel (HITSP) under contract from the Ofﬁce of the
National Coordinator for Health Information Technology, are cur-
rently underway [22,23]. The expected result of these activities
is a set of harmonized standards ready for adoption. Because
the HITSP process is ongoing, this paper will preferentially use
standards approved by HITSP, augmented by other standards as
needed.1 Both the speciﬁcations and a reference parser are available under an open source
cense from http://medir.ohsu.edu/~wrightad/sands/.4. Developing the SANDS architecture
4.1. Introduction to the prototype
Some architectures and standards have been developed in a
vacuum (that is, without a real, working prototype). Experience
suggests that development of any architecture is most likely to
be successful when it proceeds in parallel with development of a
prototype [24]. There are bound to be challenges, edge cases or
special requirements which simply cannot be anticipated when
an architecture is developed by simply writing it down.
To that end, as we proceeded through research on the SANDS
architecture, we simultaneously developed a working prototype
of the architecture, as well as a prototype EMR. Together, these
prototypes provided useful tools to test assumptions about the
architecture and they also helped to further specify the architec-
ture. While the full technical speciﬁcation of the architecture is
available, no written speciﬁcation can be fully speciﬁed withoutambiguities. These prototypes, which are also available publicly
under an open source license, help increase the speciﬁcity of the
architecture’s description.1
4.2. Overview of the NHIN
As described in the previous section, the SANDS architecture
has two interface facets: the patient data interface (here, the NHIN)
and the decision support interface. Because there is currently no
actual NHIN, we chose to use a prototype NHIN. The Ofﬁce of the
National Coordinator for Health Information Technology (ONC)
funded four consortia (led by Accenture, IBM, Northrop Grumman
and CSC) to develop prototype NHINs. Each prototype was required
to connect local exchange efforts in three distinct geographic mar-
kets. For the SANDS prototype we interfaced with the prototype
developed by CSC and the Markle Foundation which unites ex-
changes in Indianapolis, Massachusetts and Mendocino, CA. This
prototype was selected because it was the most mature at the time,
had the greatest diversity of local exchange architectures and be-
cause it was freely available.
Most decision support interventions will require two types of
data to make their inferences. First, inferences generally require
data which describe the context in which inferences are being
made. Second, inferences also frequently require more general
background data about the patient, beyond the current context.
For example, a drug interaction checker needs to know the drugs
that are about to be ordered (the contextual data), as well as the
drugs a patient is currently taking (the background data). Without
both types of information no inference can be made.
In the SANDS architecture contextual data come from the cur-
rent invocation but background data come from the NHIN. The
key advantages of using the NHIN for background data are the abil-
ity to consolidate patient data from multiple sources and the stan-
dardized view of patient data that an NHIN affords.
4.3. Querying the NHIN
The NHIN prototype used in this paper is queried over the Inter-
net. The query is a standard SOAP message—an XML standard for
making remote function calls over the Internet. The payload of
the message is an HL7 XML request formatted in accordance with
the technical guidelines of the Markle Foundation’s Common
Framework (http://www.connectingforhealth.org/commonframe-
work/). This query includes demographic information about the
patient, which is used by the NHIN’s record locator service (RLS)
to ﬁnd him or her. Eligible ﬁelds include ﬁrst and last name, date
of birth, street address, city, state, ZIP code and institution-speciﬁc
medical record numbers. The RLS uses a matching algorithm to lo-
cate relevant patient records, and passes this list to a disburser–
aggregator (D/A) service which sends queries to clinical sites which
maintain information about the matched patient. The Common
Framework does not require that an RLS have any overarching
master patient index or that an RLS assign an NHIN-wide patient
identiﬁer, so all queries to and through the RLS or D/A service
are made with a full set of demographic query information, rather
than passing an NHIN-level identiﬁer. These systems retrieve the
relevant records and return them to the D/A service which in turn
aggregates them and returns them to the requestor. All of these
transactions are carried out in accordance with a detailed set of
privacy, security and access control requirements, also described
by the Common Framework.li
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The NHIN’s response is a series of XML-formatted HL7 data ele-
ments. The data elements used vary depending on the type of clin-
ical information represented. For example, Z01 Orders are used for
medication records and Z01 Observations are used for lab results.
Figs. 1 and 2 show two example results. Fig. 1 shows the XML for-
mat used to represent a simple lab result, and is labeled to show
the following critical data elements:
1. A Logical Observation Identiﬁers Names and Codes (LOINC)
code. LOINC is a standardized terminology for expressing obser-
vations, including lab results. This LOINC code represents abso-
lute lymphocyte count.
2. A human-readable name describing the result.
3. The result value.
4. The units (in this case, thousands of cells per microliter.
5. A time stamp.
The complete interpretation of the data in Fig. 1 is that the pa-
tient had an absolute lymphocyte count of 1.4 thousand cells per
microliter on April 17, 2001. This is a simple example—however,
more complex examples, such as microbiology cultures with anti-
biotic susceptibility can also be represented using HL7 standard
extensions of this message format.
Fig. 2 shows a medication dispensing record. The most critical
ﬁelds of this record, which are labeled in the diagram, include:
1. The time stamp for the medication record.
2. An NDC code for the record, as well as a human-readable
description.
3. The route.
In this case, the complete interpretation is that 325 mg ferrous
sulfate tablets were dispensed to the patient on April 14, 2006.
4.5. The patient data class library
While, fundamentally, the patient data interface is the NHIN, as
we developed prototypes it quickly became clear that parsing rawFig. 1. A sample lab result record from the NHIN. The record is formatted as an HL7
observation segment and indicates that an absolute lymphocyte count of 1.4 tho-
usand cells per microliter on April 17, 2001.data from the NHIN was time consuming. Thus, we developed a pa-
tient data class library, described in this section, which takes data
from the NHIN and processes it into a form more usable for com-
mon decision support tasks. This class library is in the spirit of a
virtual medical record or VMR [25]. While the class library, itself,
is read-only, since it represents a view of data in the NHIN, new
contents can be added simply by publishing data to the NHIN, in
accordance with the mechanisms that the NHIN itself provides.
The foundation of this class library comes from the data ele-
ments section of a functional taxonomy of clinical decision support
which we previously published [26]. This taxonomy was based on
a thorough analysis of clinical decision support rules in use at Part-
ners HealthCare system, and laid out an exhaustive list of the trig-
gers, data elements, response actions and choices offered by these
rules. The Patient Data Class Library makes each of these elements
available to developers of decision support systems. In addition to
greater ease-of-use the Patient Data Class Library also allows for
more expansive prototyping of decision support interventions. Be-
cause current NHIN prototypes are in early stages they do not al-
ways support the complete complement of data types described
in the taxonomy. However, the Patient Data Class Library provides
a way around this limitation. In addition to its built-in support for
populating data elements from the NHIN, it can also be populated
with coded test data for use in experiments. This makes it possible
to prototype decision support systems that require data not yet
available in early stage NHIN prototypes. This feature also allows
us to create custom test patients for certain decision support inter-
ventions. For example, the NHIN prototype did not contain any
pediatric patients, but one test case we developed was for diagnos-
tic decision support with a special focus on pediatric patients. We
were able to use the test-data feature of the Patient Data Class Li-
brary to test such interventions on simulated pediatric patients.
4.6. Elements of the patient data class library
The speciﬁc elements of the Patient Data Class Library are:
Demographics and vital signs:
 First Name
 Last name
 Gender
 Race
 Date of birth
 Weight
 Height
 Care setting
Clinical information:
 Observations
 Drugs
 Problems
 Family history
 Procedure history
 Allergies
 Other orders
For each of these elements one or more standard representa-
tion forms were chosen. Where possible these representation
forms were based on standards approved by the Health Informa-
tion Technology Standards Panel (HITSP) or the Consolidated
Health Informatics working group (CHI) of the Federal Health
Architecture (FHA) project, a coalition of federal agencies which
work together to choose standards for sharing among federal
agencies [27]. The efforts of CHI have recently been mostly sup-
planted by HITSP, but there are cases where CHI standards are
Fig. 2. Sample medication record from the NHIN. This record indicates that 325 mg ferrous sulfate tablets were dispensed to the patient on April 14, 2006.
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chosen. A summary of the chosen standards and representation
formats is given in Table 1, with more detail provided in this
and subsequent sections.
Storing the patient’s ﬁrst name and last name is easy because
these are simply free-text string elements. Gender and race are
both stored according to enumerated types deﬁned by HL7, the
‘‘HL7 Gender Vocabulary Domain” and the ‘‘HL7 Race Vocabulary
Domain”. These vocabulary domains are intentionally extremely
inclusive and are designed to be able to represent any patient’s
race or gender, regardless of whatever special conditions may
apply.
Date of birth is stored as an HL7 formatted date (such as:
YYYYMMDD or 20070405), while weight and height are made
available in both metric and standard units. Weight and height
are special data elements as patients often have serial weight
and height measurements stored. In such cases the most recent
weight and height are available as discrete elements, but all his-
toric weight and height measurements are made available in the
observations section of the class library. The observation section
also allows metadata to be encoded; for example, whether the
height and weight are patient-reported or whether they were mea-
sured in the doctor’s ofﬁce. Clinical decision support interventions
that make signiﬁcant use of these data elements should process theobservations section directly to determine the best weight and
height to use in their inferences or calculations.
The ﬁnal element of the demographics and vital signs section of
the Patient Data Class Library is care setting (for example, whether
the patient is in the doctor’s ofﬁce for an ambulatory visit, is in a
skilled nursing facility, or is currently admitted to the intensive
care unit). In the case where more than one care setting applies
to a patient at a given time, the highest acuity care setting is used.
These care settings are encoded according to the HL7 ‘‘Dedicated
Clinical Location Role Type.”
4.7. Storing observations
Observations, which include such data elements as lab results,
vital signs, nursing documentation and structured data entered
by a physician are all made available through the Patient Data Class
Library. For the current implementation of the library these ele-
ments are available in a form derived from the EHR-Lab Interoper-
ability and Connectivity Speciﬁcation (ELINCS) [28]. Each
observation made available through the Patient Data Class Library
contains a timestamp, a Logical Observation Identiﬁers Names and
Code (LOINC), a value and, where applicable, the units that value
was measured in, a normal range and a result ﬂag indicated
whether or not the value is abnormal. The LOINC vocabulary stan-
Table 1
Data elements available through the Patient Data Class Library and the formats in
which they are represented
Data elements Storage format
First name Free-text string
Last name Free-text string
Gender HL7 Gender Vocabulary Domain
Race HL7 Race Vocabulary Domain
Date of birth HL7 formatted date
Weight Numeric value in kilograms
Height Numeric value in centimeters
Care setting Dedicated Clinical Location Role Type
Observations ELINCS with LOINC
Drugs National drug codes
Problems SNOMED and ICD-9
Family history HL7 Personal Relationship Role Type and
SNOMED or ICD-9
Procedure history CPT or SNOMED
Allergies SNOMED
Other orders ELINCS, HL7 version 3 acts and CPT
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Patient Data Class Library, and ensures that observations provide
not only syntactic but semantic interpretability.
4.8. Storing drug information
Drug information in the Patient Data Class Library is stored
according to national drug code (NDC), name of drug, dosage
instructions, start date, end date and the date that the prescription
was last ﬁlled. Selecting an appropriate drug vocabulary system
was especially difﬁcult and is discussed more fully in the discus-
sion section. However, for most clinical decision support interven-
tions, the current mode of storing drug data is sufﬁcient; and,
where more precise data are required, a decision support invention
can bypass the Patient Data Class Library and query the NHIN
directly.
It is important to note that the drug information we had access
to through the NHIN prototype is based on claims data, which
means that certain medication orders may be missing (particularly
in the case where samples are dispensed, or drugs are received
through a charity pharmacy or a prescription assistance program
and no claim is ﬁled). It would be useful if future generations of
the NHIN provided medication orders directly from provider EHRs,
and even perhaps progress notes. A drug terminology other than
NDC would be used in this circumstance, as NDC codes are gener-
ally used for fulﬁllment of prescription drugs, and are much too
granular for physician orders. The VA’s National Drug File Refer-
ence Terminology (NDF-RT) is one example of a drug terminology
designed for medication ordering rather than fulﬁllment, and
would be a more appropriate choice.
4.9. Storing problems
Patient problem list data includes a code describing the prob-
lem, a start date, end date, status, veriﬁed date, and comments.
Problems can be encoded either according to the ICD-9 or SNOMED
vocabularies with SNOMED strongly preferred. ICD-9 is available as
a choice only because many clinical information systems provide
problem data in ICD-9 format. It is important that any clinical deci-
sion support intervention be able to interpret problem list entries
in both ICD-9 and SNOMED, or that such an intervention takes
advantage of a translation layer to convert between the two prob-
lem vocabularies. Several such translation systems are available,
including a commercial mapping developed by the American
Health Information Management Association (AHIMA) and the
Uniﬁed Medical Language System Metathesaurus, produced by
the National Library of Medicine [29].4.10. Family history
Family history items are actually special cases of the problem
element type. Each family history element is composed of a prob-
lem (in this case, a problem that a family member rather than the
patient had), the relationship of the person suffering from the
problem to the patient, the vital status of the problem sufferer
(alive, dead or unknown), his or her current age, and age at diagno-
sis. Relationships are encoded according to the HL7 ‘‘Personal Rela-
tionship Role Type.”
4.11. Procedure history
Procedure history elements are composed of a code (either a
Current Procedural Terminology (CPT) code, or a SNOMED code),
indication, service date and comment. The indication is stored as
a problem type as described above.
4.12. Allergies
Perhaps the most difﬁcult data elements to represent in this Pa-
tient Data Class Library are the allergies. Current standards for
exchanging data on patient allergies are immature. The most de-
tailed recommendation about allergy representation comes from
a recommendation made by CHI to the Secretary of Health and Hu-
man Services. This recommendation has been reviewed by the Na-
tional Committee on Vital and Health Statistics, although adoption
of the standard is extremely limited. The recommendation portion
of the document actually recommends 23 separate vocabulary
standards for encoding the three key elements of an allergy
description: the allergen, reaction and severity. The Patient Data
Class Library uses a simpliﬁed system for encoding allergies,
employing SNOMED to describe the allergen, reaction and severity.
There are currently efforts underway, through HITSP, to harmonize
allergy standards and release a single, deﬁnitive implementation
guide for allergy encoding. As these standards mature, the Patient
Data Class Library will be extended to match developments in the
allergy domain.
4.13. Other orders
The ﬁnal area of the Patient Data Class Library is other orders.
This includes all non-drug orders, including laboratory orders,
nursing orders and procedure orders. Laboratory orders are en-
coded according to ELINCS, nursing orders according to HL7 ver-
sion 3 Acts, and procedure orders according to CPT. The choice of
Acts for nursing orders was difﬁcult, as there is no widely used
vocabulary standard for nursing orders. However, there is cur-
rently a promising effort underway to integrate a nursing order
terminology system developed by Matney et al. at Intermountain
Healthcare [30] into the HL7 version 3 RIM Act hierarchy.
4.14. Caching
Early tests of the patient data class library revealed unaccept-
able performance, primarily due to very slow fetch time of data
from the NHIN prototype (fetching all data for a patient took 6–
10 s). Analysis revealed that the delays were not primarily due to
network latency, data transfer time or XML parsing overhead,
but, instead, were a function of the current NHIN prototype’s rela-
tively slow performance in retrieving data from the original data
sources. This performance could likely be improved through a
combination of strategies such as indexing and using more efﬁ-
cient data structures and algorithms. However, the internal design
of the NHIN was outside of our control, so, to work around this
problem, we employed a caching strategy. The ﬁrst time data are
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that data from the NHIN and caches it. The library actually caches
two different data elements: ﬁrst, the entire raw response from the
NHIN, and second, a materialized instance of the Patient Data Class
Library. This allows client applications to avoid re-querying the
NHIN, regardless of whether they access patient data through the
class library or by directly parsing the NHIN response.
Because the SANDS architecture is distributed, it would be inef-
ﬁcient if every node had to keep a cached copy of the patient’s data.
Instead, a wide-area distributed hash table is employed. The hash-
ing function is implemented by the patient data class library using
the NHIN query parameters, and the table is implemented by the
memcached system [31]. The memcached system is widely used
for data-driven web and web-service applications, such as Wikipe-
dia. One important question with any caching strategy is currency,
and two approaches are used in the prototype to help ensure that
data retrieved from the cache is current. First, all data entered into
the cache is given a short expiration time (a few hours), and sec-
ond, when new data are stored for a patient, the cached data ob-
jects for that patient are explicitly expired from the cache. In the
present implementation, the clinical system is responsible for forc-
ing expiration, but in the ﬁnal form this would likely be a function
of the record locator service. When the RLS received notice of new
patient data from a clinical system, it would automatically expire
that patient’s cached data objects (or possibly even force an update
of them).
The caching strategy reduced the overhead of retrieving data
from several seconds to between 0.1 and 0.3 seconds, ultimately
allowing for acceptable performance, as described in the evalua-
tion section.4.15. Decision support service interface
In addition to the Patient Data Class Library the architecture de-
ﬁnes a decision support service interface. This interface is fully de-
scribed and speciﬁed in the schema and description available
online or from the authors, but some of the critical design decisions
are described in this section. The decision support service interface
consists of two components: one for invoking decision support ser-
vices, and the other for returning structured interventions. Both
components derive directly from the functional taxonomy de-
scribed previously [26] in order to maximize their applicability
to real clinical decision support scenarios.4.16. Decision support service invocation interface
The decision support and service invocation interface is derived
from the trigger axis of the decision support taxonomy. This inter-
face deﬁnes the way in which decision support services are in-
voked according to triggering clinical events. The general format
for invocation is:
RULE(PATIENT_ID, ATTRIBUTES)
Consider, for example, a decision support service designed to
alert a clinician when an extremely high or low lab value (some-
times called a panic value) is stored. This service will be called
whenever a new lab result is stored by a clinical system, a lab re-
sult stored trigger would be used:
LABRESULTSTORED(‘‘123456”,‘‘RESULT=2697-1”);
The two arguments passed to the Lab Result Stored invocation
are an identiﬁer for the patient (keyed to the NHIN Master Patient
Index by ID 123456), and a LOINC code describing the result is also
passed to the service. In this case, the code is 2697-1, which is the
code for a serum potassium value. It is important to note that theactual result is not passed along with the invocation. It is the
responsibility of the decision support service to fetch whatever pa-
tient data are needed through the standard NHIN interface, thus
freeing the calling clinical system from having to predict what data
elements the clinical decision support service needs to make an
inference.
The invocation interface is built on top of standard Web service
protocols, particularly SOAP, WSDL and UDDI. SOAP is a format for
making remote object-oriented function calls. The invocation calls
shown above look like local function calls, but they actually rely on
SOAP to transport the function call to a remote service, and also to
transport the result of that remote function call back to the caller.
SOAP toolkits are available for most modern languages, including
C, C++, C#, Java, PERL, Python, Visual Basic, PHP and Ruby. These
toolkits make the details of calling remote functions transparent
to the users. SOAP is, in turn, dependent on the WSDL standard,
a way of describing remote functions. So, for example, the fact that
a remote method called LabResultStored is provided by a decision
support service, and that method requires two arguments is en-
coded in the WSDL format, which SOAP uses to encode and decode
function calls. The UDDI protocol provides discovery and descrip-
tion services, so that new web services can be found by potential
clients. All three of these standards are, in turn, built on top of
HTTP, an application layer protocol which itself is built on the
well-known TCP and IP protocols.
While the service deﬁnition speciﬁes a variety of common invo-
cation methods, it is important to note that, ultimately, the form of
invocation and arguments required is determined by the provider
of a decision support service. This provides signiﬁcant ﬂexibility
as new kinds of decision support workﬂows can be developed
within the framework of the SANDS architecture. That said, where
possible, it is certainly preferable to use the standard invocation
patterns as these are most likely to be supported by hooks in clin-
ical systems.
4.17. Structured intervention interface
The expected result of a call to any decision support service is
either instructions to take no action or a set of one or more inter-
ventions describing actions to be taken automatically by the clini-
cal system or proposed to the user. The interventions and the
choices offered axes of the decision support taxonomy form the ba-
sis of a structured message format for describing decision support
interventions. Fig. 3 shows an example SANDS decision support
intervention. This example describes a menu of interventions that
might be taken for a diabetic patient with hyperlipidemia who is
not currently on a hydroxymethylglutaryl-CoA reductase inhibitor
(a class of drugs used to lower cholesterol). This response consists
of the following parts:
1. A preamble, which describes the decision support rule that
triggered the response.
2. A ‘‘notify” action, which prompts the receiving clinical sys-
tem to notify the user of the information and options con-
tained in the body of the message. This notiﬁcation has
severity 3 (the lowest severity).
3. The text of the notiﬁcation: in this case ‘‘Patient has diabetes
and most recent LDL (144) above target (100) and not on an
HMG CoA-reductase inhibitor. Recommend HMG CoA-
reductase inhibitor if not allergic.”
4. A GUID, or globally unique identiﬁer. A GUID is a guaran-
teed-unique serial number. Decision support services have
the option of passing a GUID along with their response to
a query. If they do, the calling clinical system is responsible
for returning the choice taken by the user along with the
GUID to the decision support service that provided the inter-
Fig. 3. Sample response from a SANDS decision support service. This response indicates that the patient’s low density lipoprotein level is elevated and offers the user a variety
of possible responses, including starting the patient on simvastatin, an antihyperlipidemic agent.
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sion support or for statistical purposes, such as evaluating
the usefulness of the decision support intervention. For
example, if the designer of the intervention described here
discovered that clinicians were often refusing the interven-
tion because of cost reasons to patients, the CDS designer
might revise the intervention to use a less expensive drug.
5. A choice, to be offered by the clinical system to the user to
order simvastatin, a generic HMG CoA-reductase inhibitor.
6. A choice to add an allergy to the HMG CoA-reductase inhib-
itor drug class.
7. A choice to add non-alcoholic cirrhosis to the patient’s prob-
lem list—this is a contraindication to HMG CoA-reductase
inhibitor therapy.
8. A series of un-coded options to decline the suggested ther-
apy for other reasons.
9. An option to remove diabetes from the patient’s problem list
(this rule applies only to diabetic patients).
10. Options to defer the suggestion for ﬁve days, one month or
three months (‘‘P5D”, ‘‘P1M” and ‘‘P3M,” respectively—these
time durations are formatted according to ISO 8601).
While the structured intervention message format describes the
overall behavior that a clinical system should carry out, it is impor-
tant to note that it does not describe the precise way that the clin-
ical system carries that behavior out. For example, consider an
alert triggered by a patient’s rising potassium value. The decision
support service would send a Notify event, but the clinical system
would have to determine what to do with it. If the responsible cli-
nician is currently logged in to the computer the clinical system
might provide a pop-up or other contextual alert that a notiﬁcation
is available and allow the clinician to choose a response from the
provided menu. However, if the responsible clinician is not logged
in, the clinical system might instead page him or her with the
information.
One signiﬁcant challenge is how to reconcile actions across clin-
ical systems. For example, consider the case where, in response to adrug–drug interaction alert, a provider chooses to discontinue a
medication ordered by another provider in another clinical system.
There are a number of important clinical issues that arise in this
case—should the provider who ordered the now discontinued med-
ication be alerted? How should this discontinuation be updated in
his or her clinical system? Is it acceptable for one provider’s med-
ication list to be updated by the actions of another provider, and if
so, under what circumstances? As medical record systems and
medical information become increasingly distributed, consensus
will have to be reached around these complicated technical and
ethical questions.
5. A reference parser
The formal service deﬁnition is sufﬁcient to fully describe the
representation format used by that standard, both with regards
to triggers and to structured intervention responses. However,
experience suggests that interpretation of such a standard will be
most faithful when a working implementation of the standard is
also provided to interested developers. As such, we have made a
reference parser available under an open-source license. Anyone
interested in developing a service to participate in this architecture
should ensure that the results that their service provides can be
successfully interpreted by this reference parser. Anyone inter-
ested in developing a clinical system that parses results of decision
support services should use the reference parser as the foundation
or at least ensure that the parser that they develop has the same
behavior as the reference parser.
6. Building a prototype
6.1. Prototype electronic health record
To showcase this decision support architecture and service
interface, we developed a prototype electronic health record, called
the SANDS Prototype Client. The SANDS Prototype Client has most
of the functionality of a regular electronic health record, along with
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electronic health records because instead of having its own inter-
nal data store it accesses the NHIN prototype to retrieve patient
information. It features a problem list viewer and entry system
(which updates the NHIN), a results viewer, a medication list view-
er and entry system and a progress note viewer and editor. All of
these data are read from the Patient Data Class Library, which, in
turn, reads data from the NHIN prototype. The other unique feature
of the SANDS Prototype Client is, of course, its support of the
SANDS architecture.
The next six sections of the paper describe sample use cases
developed according to the decision support service deﬁnition de-
scribed earlier in this paper and more formally in the service
description and schema available online. These use cases were
developed to provide real-world validation of the architecture con-
templated and the interfaces developed for it.
6.2. Drug interaction checking
The ﬁrst use case is drug–drug interaction checking. Many med-
ications, when given in combination, interact, leading to a variety
of possible adverse results including direct toxicity, or overactivity
or underactivity of one or both of the interacting medications.
These interactions are frequent, and can be dangerous [32–35].
However, automated alerting systems can be effective at reducing
both the rate of interacting medication orders, and harmful ad-
verse sequelae [36–40].
However, integrating the databases containing the drug–drug
interaction knowledge into clinical systems can be difﬁcult, and
in many cases, vendors of clinical systems have relationships with
a single drug information database provider limiting users of these
clinical systems to only that drug information provider. In this use
case, we developed a service for drug interaction checking based
on a commercial drug information database developed by Lexi-
Comp, Inc. (Hudson, OH). The Lexi-Comp database was chosen be-
cause Lexi-Comp offers a pre-existing web service interface, which
could be readily adapted to the standardized interface developed
here.
The SANDS prototype client supports calling the drug interac-
tion service in two modes: ﬁrst, it can be called when the user
clicks the ‘‘Check Drug Interactions” button. This button checks
the patient’s current consolidated medication list for drug interac-
tions. Second, the service can be called automatically when a new
medication is ordered, to check for interactions between that med-
ication and the rest of the patient’s medication list.
Consider a sample case where a patient is taking both meperi-
dine and his or her physician attempts to order the monoamine
oxidase inhibitor phenelzine. This combination can precipitate a
hypertensive crisis and ultimately cause death. When the user en-
ters the second order in the EHR, the EHR contacts the drug–drug
interaction to request a check of the new request. This request is
shown in Fig. 4. The drug interaction service compares the new
medication order to the patient’s current medication list and gen-
erates a SANDS-formatted response, shown in Fig. 5, which gener-
ates an alert shown to the user directly inside of the EHR.
Integrating the existing Lexi-Comp drug–drug interaction ser-
vice with the prototype EHR using the SANDS architecture was
achieved quite easily. The only major issue encountered in the
integration process related to the threshold for alerts. It is widely
thought that commercial drug information databases have too
low a threshold for alerts (i.e., that they alert too often, and that
many alerts they provide are not clinically relevant) [41–44], and
that appeared to be the case here. The Lexi-Comp drug interaction
service has a severity grading system, but alerts graded at the high-
est levels—those alerts that Lexi-Comp classiﬁes as needing human
intervention—are extremely common. For example, one sample pa-tient’s consolidated medication list yielded 750 alerts, 685 of
which were graded as requiring human attention. While some of
the interactions were clinically signiﬁcant (such as the example
presented above), it would be impractical for a clinician to review
685 separate alerts. Before a drug–drug interaction service could
be deployed for real-world use, it would be important to thought-
fully pare down the interaction database, a process already under-
way at some advanced sites [45,46].
6.3. Syndromic surveillance
The next use case we developed was for syndromic surveillance
and reporting of reportable diseases to public health authorities.
Unlike the previously presented use cases, there was no pre-exist-
ing service for this function. Instead we developed the decision
support system de novo based on published documents from the
Oregon Health Department. As in most states, epidemiologists at
the Oregon Health Department track the spread of a variety of
infectious disease. One key element of this tracking program is
mandatory reporting of diseases. Some of this reporting is carried
out by medical laboratories which are obligated to report positive
tests for diseases in reportable groups. However, certain diseases,
such as pertussis, are often diagnosed solely on clinical factors,
so the responsibility for reporting the disease falls on the provider
that made the diagnosis. Although data about how often reportable
diseases are actually reported are sparse, it is widely believed that
there is signiﬁcant underreporting of diseases, largely due to pro-
viders who either are not aware of the rules or who do not have
the time to comply with them. To support both providers and pub-
lic health authorities we developed a reporting system which takes
all new diagnoses, at the time they are entered by providers, and
runs them through a ﬁlter to determine whether or not they repre-
sent reportable diseases. This use case makes interesting use of the
SNOMED terminology. Problems reported to the decision support
system are reported according to SNOMED concept ID’s, which pro-
vides a good level of speciﬁcity. In many cases, determining
whether a disease is reportable or not is a simple matter of com-
paring the concept ID being reported to a list of the concept ID’s
for reportable diseases. However, in certain cases, the analysis is
more complex. Consider, for example infection by the organism
Nesseria gonorrhoeae, which is reportable under Oregon law. While
a SNOMED concept ID (15628003) exists for such an infection,
there are actually 90 clinical concepts which descend from this
term, all of which would be considered reportable in Oregon. How-
ever because SNOMED has a robust semantic structure it is unnec-
essary to identify, a priori, all of these concepts. Instead, the rule is
deﬁned to include SNOMED concept 15628003, and all of its
descendents. If, in the future, new problems are added under con-
cept 15628003, any decision support system which uses the
semantic structures of SNOMED will automatically have the bene-
ﬁt of these updates, without needing to be modiﬁed.
In the current embodiment of this prototype, whenever a new
problem is entered into the prototype electronic health record
which is reportable under Oregon law a pop-up alert is given to
the user based on a database which describes the reporting
requirements for each disease. The alert informs the provider
whether or not they need to contact the state epidemiologist di-
rectly or whether the automatic notiﬁcation already sent is sufﬁ-
cient. If it is necessary to contact the epidemiologist, the system
provides detailed information to the clinician about the phone
number to call and how long he or she has to report the disease.
This is important because some diseases require immediate con-
sultation with the epidemiologist while others can be reported
days later.
Fig. 6 shows an example of this feature. In this case, a diagnosis
of pertussis was entered for a patient who lives in Multnomah
Fig. 4. A SOAP request showing an invocation of the DDI web service. Mark 1 shows the medication being ordered (the contextual data) for the drug phenelzine, a monoamine
oxidase inhibitor. Mark 2 shows the data used to locate the patient in the NHIN. Although a site speciﬁc MRN is included, the RLS uses this information to ﬁnd records for the
patient at any participating site.
Fig. 5. A SANDS-formatted response from the DDI service. The response indicates that there is a potentially fatal interaction between the ordered drug, phenelzine and the
drug meperidine which the patient is currently taking. Because the reaction is so severe, the only choice offered is canceling the order—the user cannot proceed.
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Multnomah County, the reporting number for the appropriate
health department is also provided. This service stands out
amongst the others in that it not only provides an interface to an
electronic health record, but also provides a separate interface to
public health management systems. In this case, an epidemiologist
with proper authorization can query the system for a list of all
cases that match certain query parameters. For example, an epide-
miologist might query the database to see where cases of pertussis
were reported within the Portland metropolitan area over the past
seven days. The current prototype system then links to Google
Earth, a 3-D map visualization program to provide a geospatial rep-
resentation of the cases in the database. Fig. 7 shows this visualiza-
tion. This requires that the disease reporting service, in turn,
consults a geocoder service. Geocoding is the process of taking
an address as might be stored in a patient’s electronic health record
and converting that address to a spatial location, usually the lati-
tude and longitude at that point.
In the typical interaction between the electronic health record
and the reporting service, the EHR would send a problem-added
invocation to the reporting service. If necessary the reporting ser-
vice would respond to the EHR with a notify intervention, explain-
ing that the problem most recently added represents a reportable
disease.
This use case demonstrates three special aspects of this archi-
tecture. First, it shows the ability of a single service to provide deci-
sion support to two different kinds of clinical systems. There are
many use cases where this could be helpful: for example, a drug al-lergy warning service which interfaces with both an electronic
health record and a personal health record.
Second, this use case demonstrates service composition: the
reporting service contacts another service, the geocoder, to com-
plete its work. Many cases of decision support will use service
composition. For example, a therapeutic reminder system might
ﬁrst query an allergy system to determine whether or not the ther-
apy that it is about to suggest is contraindicated due to a patient
allergy.
Third, this use case demonstrates the ability to modularly re-
place services. In this project and another related project, per-
formed for the Oregon State Health Department, six different
geocoding services were reviewed. Each of the services has advan-
tages and disadvantages, with their primary differentiation being
the quality of their mapping and their cost. A number of free ser-
vices are available, provided by Google (http://www.google.com/
apis/maps/documentation/), Yahoo (http://developer.yahoo.com/
maps/rest/V1/geocode.html) and others. These services generally
use free but lower quality maps (such as the Census Tiger Line File).
Paid services generally use higher quality maps, such as those from
Tele Atlas (Tele Atlas NV, Ghent, Belgium) and Navteq (Navteq
North America, Chicago, Illinois). Because one of the goals of this
project is to showcase free software and free services, and because
accuracy down to be house level is not especially important for the
public health use case, we chose to use the Google geocoder ser-
vice. The ability to freely choose from a variety of decision support
services makes development, testing and maintenance of software
much easier, and it is hoped that one day the robust and compet-
Fig. 7. Simulated pertussis cases from the syndromic surveillance/reportable disease service, as viewed in Google Earth.
Fig. 6. An alert reminding the clinician that pertussis is a reportable illness in Oregon and providing instructions on how to report it. This alert was raised because the user
added pertussis as a problem in the background EHR window.
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replicated for decision support services.
7. Diagnostic decision support
The next use case is a diagnostic decision support system. In our
prototype architecture, we built an interface between the Isabel
diagnostic decision support system (Isabel Healthcare, Reston, Vir-
ginia) and our prototype electronic health record. The Isabel sys-tem uses rudimentary natural language processing techniques to
provide clinical decision support directly from the medical litera-
ture and medical textbooks instead of using a comprehensive
coded knowledge base of medicine as previous systems have. It
compares the structure and semantic content of these books with
a narrative report entered by the user. In this case the SANDS inter-
face with Isabel sends the subjective and objective components of
a progress note, as entered in our prototype electronic health re-
cord system, to Isabel for processing.
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their product to be integrated with EMR systems. This interface
was proprietary, however, so we developed a wrapper to map
the proprietary interface to the SANDS architecture standard inter-
face. In many respects this interface was the easiest that we cre-
ated because Isabel uses free text and has its own natural
language processing engine and its own thesaurus. As such, it
was not necessary to provide any coded data to Isabel so there
were no vocabulary standards issues to resolve.
Consider a simple case of a seven-year-old child with left ear
pain. The provider has entered the subjective and objective compo-
nents of his note:
SUBJECTIVE: PATIENT COMPLAINS OF THREE DAY HISTORY OF
LEFT EAR PAIN.
OBJECTIVE: LEFT TYMPANIC MEMBRANE ERYTHEMATOUS AND
SWOLLEN.
Now, before proceeding to the assessment and plan, the pro-
vider activates the Isabel decision support system over the proto-
type architecture by clicking a button in his electronic medical
record. This triggers the electronic medical record system to send
a standard message to the Isabel decision support system contain-
ing the text of the note entered so far by the practitioner, as well as
a pointer to the patient’s electronic medical record and the na-
tional health information network. The diagnostic decision support
system uses this note as well as other background information
such as demographics retrieved from the NHIN. Fig. 8 shows Isa-
bel’s response.
Based on its knowledge base, Isabel provides a differential diag-
nosis list containing nine diagnoses across ﬁve physiologic sys-
tems. In this case, the ﬁrst diagnosis proposed by Isabel is the
correct one. Although this case may appear trivial to a human, it
is still impressive given the past challenges that diagnostic deci-
sion support systems have faced. Published evidence suggests that
Isabel provides good accuracy, even in very complex cases [47–50].
One difﬁculty encountered in integrating Isabel into the deci-
sion support workﬂow was the fact that, in current versions, Isabel
provides its differential diagnosis results in an unstructured for-
mat. This precluded developing a feature allowing the user to click
a diagnosis in Isabel and have it automatically added to the pro-
gress note or problem list. In future work, we hope to map Isabel’s
diagnoses to SNOMED so they can be more readily integrated into
clinical systems. Were such codes already available, we would use
the addProblem response type so that a compliant electronic
health record system could automatically add the chosen diagnosis
to the problem list.
7.1. Inappropriate prescribing in older adults
The next use case is a drug-therapy decision support system de-
signed to assist clinicians in prescribing medications for older
adults. To this end, an expert consensus panel developed guide-
lines which specify drugs which are either unsafe in older adults,
or which require dose adjustment [51]. Although these guidelines
are available, it is well-known that such drugs are still frequently
used in older adults, even when better alternatives are available
[52].
Because no existing Beers criteria decision support service was
available, we developed one, based on the guidance published in
Archives of Internal Medicine [51]. Fig. 9 shows a sample alert
raised by the service, in response to an order for metaxalone (Skel-
axin, a skeletal muscle relaxant) in an 83-year-old female.
The inference pattern of this service is simple rule-based rea-
soning. The service maintains a memory-resident associative array
(or dictionary), which binds medications to alert text. When the
service is invoked for a new medication order, it fetches the pa-tient’s age. If the patient is 65 or younger, no alert can be returned,
and the logic terminates. If the patient is over 65, the array is que-
ried for the medication being ordered (an O(1) operation). If the
medication is not found, no alert is returned, and the logic termi-
nates. However, if an alert is found, a notify response containing
the appropriate alert text is generated and returned to the request-
ing clinical system.
One interesting facet of this use case is the method by which its
content was developed. While the Beers criteria were developed by
an expert consensus panel, it has been formatted for use in a clin-
ical information system through a wiki (the Clinfowiki: http://
www.clinfowiki.org) using what Benkler has called ‘‘commons-
based peer production” [53]. In this model, collaborators (including
the authors of this paper) have worked to reﬁne the criteria, add
alert text and put the data into machine-readable format using
wiki software [54]. This method seems to work fairly well, and
the alerts are now available online (http://www.clinfowiki.org/
wiki/index.php?title=Tab-separated_ﬁle_of_Beers_criteria_alerts),
under the GNU Free Documentation License.
7.2. Information at the point of care
During the course of caring for patients, clinicians have a variety
of information needs [55]. More recent studies have found similar
results, and while use of computers for point of care information
needs is increasing, print sources still dominate [56–58]. It is
known that, given the right tools, clinicians are willing to use elec-
tronic reference sources [58,59], and that good, usable electronic
references sources exist [60].
However, it has been difﬁcult to connect clinicians to these elec-
tronic resources for two reasons: ﬁrst, clinicians who are using an
EHR and who wish to consult such a source must generally open a
web browser outside of the EHR, access the reference source and
log-in, and then must consult the source, while possibly switching
back and forth between the EHR and the reference source. These
context switches impose a high cognitive burden. Second, clini-
cians frequently have contextual questions—for example, they
are ordering a drug, and want information on appropriate dosing.
In many cases, they have already created this context in their
EHR by, for example, starting an order, and then they are forced
to re-create the same context in the separate information tool. Var-
ious attempts, such as the Infobutton standard, have been made to
more closely integrate information resources with clinical informa-
tion systems, and early results are encouraging [61,62].
In this use case, we developed a decision support system for
providing context-speciﬁc information to clinicians at the point
of care. We used two information sources for our service: UpTo-
Date and Google Co-op. UpToDate (Waltham, MA) is a commercial
source of evidence summaries for a variety of conditions that
might be encountered in primary care. It is widely used, and pop-
ular with clinicians [60]. It is also expensive. Google Co-op, on the
other hand, is free. It is a health search engine based on the main
Google index, but supplemented with tags added by 26 trusted
contributors, such as the Health on the Net Foundation, the Mayo
Clinic, Kaiser Permanente, the National Library of Medicine and
Harvard Medical School. These contributors add tags to articles,
describing the type of information they contain, thus helping to
improve the quality of search results for medical conditions and
drugs. Both of these sources use free-text search, and neither of
their indexes are linked to any structured vocabulary, so direct,
free-text search terms are passed to them through the decision
support interface.
This decision support service is accessed by context menus in
the SANDS prototype client. These menus allow the user to choose
whether they want to query UpToDate or Google. If the user wants
to query Google, there are options to narrow the search to treat-
Fig. 8. Diagnostic decision support response from Isabel, as displayed in the SANDS client. In this case, Isabel was reviewing the subjective and objective portions of a progress
note for a hypothetical patient with otitis media.
Fig. 9. An alert based on the Beers criteria. This alert was raised because the user entered a medication order for metaxalone in the background EHR window.
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guidelines, patient handouts and clinical trials. These correspond
to disease information tags in the Google Co-op knowledge base.
The same service is called regardless of what category is se-
lected, with the information category selected by the user passed
in to the decision support service as a parameter. In a typical use
case, a clinical system analyst at a hospital would use the user
interface design toolkit provided by their clinical system vendor
to develop a custom menu, where each item was a hook into aninformation service. The clinical system designer would customize
the menu items available based on the information sources that
the hospital subscribes to and the information needs of clinicians
at that hospital. In future work, we intend to replace our self-devel-
oped system with the HL7 Infobutton Manager standard [61],
which provides similar functionality with several important
enhancements, including built in support for managing content
licensing issues, which was an issue we faced several times with
UpToDate, a commercial source with license restrictions.
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The ﬁnal use case we developed was a simple personal health
record, shown in Fig. 10. It is a web-based application that a patient
would access. It provides a read-only view into the patient’s med-
ication list, as stored in the NHIN, allowing the patient to see what
medications are active across a number of providers. The personal
health record also provides drug-interaction checking and links to
information resources targeted at patients. These services are actu-
ally identical to the previously discussed services provided through
the EHR This is one of the key advantages of the SANDS architec-
ture—because decision support content is exposed as services,
the content can be reused across different end-user applications,
such as the EHR and PHR described here.
7.4. Evaluation
We evaluated the SANDS architecture according to the frame-
work described in the review paper [63] which includes four
elements:
1. Feature determination
2. Existence and Use
3. Utility
4. Coverage
In addition, we evaluated the performance of SANDS, in order to
ensure that it was sufﬁciently fast to enable use in real world clin-
ical information systems.
7.5. Feature determination
SANDS was developed with the evaluation framework’s set of
desirable features in mind, and it evaluates favorably against them.
Speciﬁcally, SANDS:
 Avoids vocabulary issues, by using the NHIN, which already
establishes vocabulary formats, to query patient data.Fig. 10. A sample personal health record, showing how SANDS services originally desig
personal health records. This example shows a patient’s medication list and allows him o
services. Is shareable, because many clinical systems and users can query
a single service.
 Maintains content separate from code explicitly by means of a
service contract where the decision support content is embodied
in a service called from the information system code.
 Enables automatic central updates because the content is stored
centrally within the service, so when the content is changed,
no corresponding changes need to be made to the calling clinical
system.
 Allows content to be integrated into workﬂows by enabling deci-
sion support services to be called from within other clinical
information systems.
 Supports event driven CDS through calls from clinical information
systems during these events.
 Supports non-event driven CDS through calls from non-event-dri-
ven systems, such as dashboards, registries and quality report-
ing applications.
 Supports decision support across multiple patients in two ways:
either by calling services repeatedly and passing in single
patient identiﬁers or, where supported, by allowing clients to
pass in multiple patient identiﬁers as part of a single query.
 Enables separation of responsibilities by placing responsibility for
maintaining content with the service developer and away from
the clinical information system implementer.
 Enables composition of rules because decision support services
can invoke other services.
 Allows black-box services where a service makes inferences and
responds to queries without necessarily exposing its underlying
logic to the client application.
 Free choice of programming language since services can be writ-
ten in any language, so long as they expose the standard SANDS
interfaces.
One important gap in SANDS’ features is the ability for the user
to view and monitor the clinical decision support content. This is
relatively easy with knowledge representation formalisms such
as Arden Syntax and GuideLine Interchange Format (GLIF), as the
user can simply look at the rules to see what they do. However,ned for use in an electronic health record can be reused in other systems, such as
r her to seek information on the medications using one of the reference information
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cuted in a service away from the clinical information system, the
user must depend on the service to provide accurate inferences.
Although the user can (and should) ask to view the source rules
for any decision support service being invoked, there is no way
to be certain that the rules have not been changed or modiﬁed. This
is, in fact, perhaps SANDS’ most signiﬁcant limitation, and is an
inherent limiting property of any service-oriented architecture.
The solutions include developing some sort of trust relationship
(likely enforced by a contract), or running local mirrors (i.e., ver-
sions of the service that are completely under the control of the lo-
cal organization’s HIT department) of decision support services—a
mode we are now beginning to prototype.8. Existence and use
In the review paper [63], we proposed an existence and use
spectrum having four steps ranging from theoretical discussions
(level 1) through widespread adoption (level 4). With SANDS, we
achieved level 3—advanced prototypes that demonstrate sharing
of decision support content across sites. The development of exter-
nal use cases, such as the Isabel diagnostic decision support system
and the Lexi-Comp drug–drug interaction system show that SANDS
can incorporate decision support beyond just use cases developed
speciﬁcally for SANDS. Over time, we hope to take SANDS through
a standards process, and eventually see its implementation in com-
mercially available clinical systems, at which point it would pro-
gress to level 4 of the existence and use spectrum. In the
meantime, we have made much of the code and services we have
developed available as free open-source software.
8.1. Utility
Utility, as deﬁned in the evaluation model, has two facets: clin-
ical utility and functional utility. Clinical utility is the ability to use
a decision support architecture to do clinically useful things. Many
of the SANDS use cases have simple face validity as possibly clini-
cally useful, but more than that, many of the decision support func-
tions prototyped have actually been studied clinically and found to
have positive impacts on quality of care and patient safety—where
these are known, references are given in the prior section describ-
ing the use cases. Because SANDS is a conduit for delivering clinical
decision support, it inherits clinical utility from the clinical utility
of the use cases implemented in it.
The other facet of utility is functional utility—the ability of an
architecture to support a variety of different kinds of clinical deci-
sion support. One advantage of SANDS is that it is extremely ﬂex-
ible. Table 2 shows the use cases we developed for SANDS
characterized across several dimensions of functional utility. As
the table suggests, these use cases exhibited a variety of functional
properties. Some, for example, were simple rule-based systems,
while others made complex inferences using NLP. We also success-
fully created prototypes of freely available decision support rules
as well as commercially available rules.
8.2. Coverage
Because the SANDS protocols and message formats were de-
rived from the same taxonomy and rule-base as the coverage eval-
uation described in our review paper, SANDS achieved 100%
coverage in the metric described in the model paper. It is impor-
tant to note that this is not meant as a comparison against other
architectures—if additional rule bases were added to the coverage
evaluation, it is possible that SANDS would incompletely cover
them, resulting in a lower coverage metric. Conversely, other archi-tectures could be extended to include the full complement of trig-
gers, data elements, interventions and response types needed to
support the evaluation rule base, thus likewise achieving full
coverage.
8.3. Performance
As mentioned in the introduction, early performance data about
SANDS was previously presented at the 2007 American Medical
Informatics Association Annual Symposium [6]. Since this presen-
tation, further performance data has been collected and additional
analyses have been performed.
A common goal of clinical system developers is sub-second re-
sponse time [64] and one critical question we faced was whether
this ideal could be achieved using the SANDS architecture. The
SANDS architecture is subject to ﬁve kinds of delay which are gen-
erally additive:
 Network latency: The time it takes for a packet to propagate
between two hosts on a network. This is a startup cost of trans-
mission—after the ﬁrst packet, throughput is governed by trans-
mission delay.
 Transmission delay: The time needed to transmit a message over
the network once latency is overcome. With SANDS’ small mes-
sage sizes, throughput is usually not a major source of delay.
 Patient data fetch: SANDS fetches a patient’s clinical data from
the NHIN. The cost of this fetch can be fairly high so SANDS
employs a caching strategy to reduce this delay.
 Parsing overhead: SANDS is based on Extensible Markup Lan-
guage (XML) protocols and there is overhead in parsing the
XML. Given the size of the messages used in SANDS, the over-
head is fairly small.
 Inference time: This is the actual time that the inference takes to
run. This is no additional overhead added by SANDS. Even tightly
integrated decision support systems face this delay.
The latency delay of a typical transmission varies signiﬁcantly
depending on the physical distance between the client and server.
Within a subnet, it is generally less than one millisecond. Within
the continental United States, we observed times ranging from 3
to 170 ms, with typical transmissions experiencing approximately
75 ms latency delay. Because the amount of data SANDS transmits
is small, transmission delay tends to be very small, on the order of
1–3 ms. The patient data fetch time is a function of the NHIN archi-
tecture and tended to be unacceptably slow (on the order of 6–
10 s). As a result, caching was employed, which reduced the fetch
delay to zero (when stored locally in the service), or on the order of
100–200 ms, when stored in the cross-service distributed cache
described previously. The parsing overhead for SANDS messages
was approximately 10 ms using Microsoft’s native XML parser.
The ﬁrst four delays are all overhead added by SANDS. The ﬁnal
source of delay, inference time, is a property of the decision sup-
port service, and was the most variable. Simple services could com-
plete their inferences very quickly (from 50 to 100 ms), while other
services took nearly a second.
To assess the robustness of the SANDS architecture and the de-
lays associated with it we conducted a timing and reliability study.
We set up the system to automatically poll each service in the
SANDS implementation every 5 min (24 h/day, 7 days/week) over
a continuous four week period (a total of 13,440 requests) and
gathered data on the average response times observed. They varied
signiﬁcantly depending on the use cases, ranging from a total end-
to-end time (including all ﬁve delays) of 73 ms for the services we
developed to 138 ms for Google’s geocoder through 1382 ms for
the drug–drug interaction service. Fig. 11 shows the range and
average times for each of the sources of delays across all the ser-
Table 2
Characteristics of use cases developed for the SANDS prototype
Diagnostic
support
POC Info: Google POC Info:
UpToDate
Inappropriate
prescribing
Drug–drug
interaction
Syndromic
surveillance
Personal health record
Developer Isabel Google UpToDate Self Lexi-Comp Self Self
User Clinician Clinician Clinician Clinician Clinician Clinician,
epidemiologist
Patient
Information
source
Textbooks Internet (expert
curated)
Expert writers Expert panel Lexi-Comp
pharmacists
State Health
Dept.
Other data sources
Clinical
purpose
Diagnosis Diagnosis/
therapy
Diagnosis/
therapy
Drug therapy Drug therapy Public health Patient information
Inference
type
NLP IR IR Rule-based Rule-based Rule-based,
geospatial
Compositional
Composition
role
None Provider Provider Provider Provider Consumer Consumer
Business
model
Subscription Ad-supported Subscription Public service Subscription Government
supported
Unclear: public service/
subscription/third party pay
Pay Yes No Yes No Yes No No
Status Already a
service
Already a service Wrapper De novo Already a
service
De novo De novo
Fig. 11. The ﬁve sources of delay in SANDS and typical delay times associated with
each.
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turned off, the NHIN fetch adds delays ranging from 6 to 10 s, over-
whelming the contributions of all other sources of delay.
As for reliability, seven of the nine (78%) SANDS decision sup-
port modules had sub-second response times >97% of the time.
Overall, these results indicate that it is not only possible, but highly
reliable and quick, to perform a variety of useful clinical decision
support interventions using the SANDS architecture with sub-sec-
ond response time as the standard. The syndromic surveillance and
prescribing in the elderly services, which were self developed, had
outstanding performance because they were optimized for efﬁ-
ciency and located locally so a request to them did not have to tra-
verse the Internet. The drug–drug interaction service never
completed within 1 s, but almost always (99.83%) completed with-
in 5 s. This is likely due to the data structures used by the devel-
oper of the service.
The last three services, called Geocoders, merit further com-
ment. The syndromic surveillance use case has a mapping capa-
bility where cases of reportable diseases are displayed
geospatially. To do this, a service called a Geocoder is used. A
Geocoder takes an address and ﬁnds the corresponding latitude
and longitude. Three different free Geocoding services were
tested and the variation in performance was striking—Google’s
Geocoder almost never failed, and returned within 1 s 99.9% of
the time. Yahoo’s Geocoder, doing the same task, failed twice as
often and took, on average, nearly twice as long. Clearly, system
reliability and performance will be an important consideration
for any user of the SANDS architecture. While the architecture it-
self imposes only minimal latency and overhead, the performanceof the same task, implemented by different developers, may vary
greatly so it will be important to carefully evaluate performance
before choosing services.
9. Discussion
9.1. Challenges in integrating data
One key challenge encountered in development of the Patient
Data Class library was data integration. The class library combines
data from multiple sources, and sometimes these data are duplica-
tive or contradictory. For some data elements, such as demograph-
ics, discrepancies were uncommon and usually of little signiﬁcance
(for example, discrepant spellings of the patient’s ﬁrst name).
When present, they were resolved by using the most recent obser-
vation as the correct one. Vital signs were resolved in a similar
fashion: all vital signs were stored and made available with time-
stamps as observations. For height, weight and care setting the
most recent value was also made available as a discrete value in
the demographics component of the Patient Data Class Library.
Integrating clinical information was more difﬁcult. For some
data elements, such as observations and procedure history, the cor-
rect integrated set is simply the union of all non-duplicate ele-
ments stored in clinical systems on the national health
information network.
However, for drugs in particular, the problem was much more
difﬁcult. We often encountered patients who had medication lists
spread across a variety of clinical systems, often containing the
same drug with different doses or two drugs in a therapeutic class
where co-administration is very uncommon. We were not able to
accurately reconcile such medication lists in a fully automated
fashion. This problem is well understood and described in the liter-
ature [65,66] and is the focus of a number of active research pro-
jects, such as the RxSafe project in Lincoln City, OR [67]. It is
likely that any comprehensive solution will require human inter-
vention, whether it’s a clinician to reconcile the medication lists,
a pharmacist or the patient himself. Luckily this problem cuts
across all uses and users of integrated medication data, so it is
likely to see signiﬁcant attention in the future.
Challenges in data integration are not solely limited to medica-
tion information. For example, various data sources may contain
differing (or conﬂicting) information and some mechanism is
needed to decide which piece of information should be used. The
current approach is to rely on the most recent instance of that data
element, but this has signiﬁcant limitations. For example, if the
most recent data element is patient entered, but there is also a rea-
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ment, perhaps it would be desirable to use this instance. The cur-
rent NHIN prototype does not always provide sufﬁcient metadata
to make these determinations, and would beneﬁt from a clearer
mechanism of indicating the relative conﬁdence and reliability of
data instances. The other option, of course, would be to prompt
the user to ask the patient which instance of the data element to
rely on. This option would be especially appropriate in cases where
the conﬂicting data instances result in clinically signiﬁcant differ-
ences in the result of the decision support inference. This mecha-
nism could also be extended to prompting the user to enter
missing data required to make an inference, such as height and
weight for inferences which depend on calculated body surface
area or creatinine clearance.
9.2. Drug terminology challenges
Many systems, including the national health information net-
work prototype that we used in this paper use national drug codes
or NDCs. These codes are popular because they are the basis of
most pharmaceutical claims. Since nearly all pharmaceutical
claims are processed electronically they tend to be much more
widely available than prescription data because electronic pre-
scribing is still rare. The most signiﬁcant difﬁculty with NDCs is
their speciﬁcity. Each individual dose form and quantity of a med-
ication is assigned a unique national drug code. That means that a
common generic drug, like aspirin, may have dozens or hundreds
of applicable NDCs. This creates a challenge for decision support,
because any rule that references a given drug by its NDC must be
aware of the fact that there could actually be many NDCs for that
drug, and that more may appear in the future. A further challenge
is that NDCs can be unreliable. The code space for NDCs is managed
in a decentralized fashion with the FDA assigning parent codes to
all manufacturers of pharmaceuticals. These manufacturers then
assign NDCs from their code space whenever they produce a new
drug. Unfortunately, there are cases where manufacturers recycle
drug codes, or simply assign the same drug code to multiple drugs.
And while manufacturers are required to report their assignments
back to the FDA, there are cases where they fail to do so. As such,
even in our limited prototype we encountered a number of situa-
tions where NDCs found on a patient’s drug list could not be
matched by decision support systems. For example, the NDC code
00093086301 represents one form of ciproﬂoxacin. When this code
was passed to the Lexi-Comp drug interaction service the query
failed. Although the service, of course, contains data on ciproﬂoxa-
cin this particular NDC for Ciproﬂoxacin was not in its database.
The same issue was encountered for NDC 68249020010 (for the
drug Humibid, a brand name version of guaifenesin with potas-
sium guaiacolsulfonate) and for NDC 00591049950 (a generic
100 MG doxycycline hyclate tablet produced by Watson
Laboratories).
It is our strong recommendation that terminologies besides
NDCs be used to describe drugs. The National Drug File Refer-
ence Terminology (NDF-RT) would be one good choice, but
there are actually many. This cause is helped by the RxNorm
project of the National Library of Medicine [19]. RXNorm is de-
signed to be a comprehensive map amongst various drug termi-
nologies. While it includes NDCs, it faces the same limitations
that other terminology systems based on NDCs have encoun-
tered: namely, that certain NDCs which have been assigned to
drugs do not appear in RxNorm. Another ray of hope comes
from the NCPDP SCRIPT electronic prescribing standard [16].
Electronic prescriptions using NCPDP SCRIPT use robust drug
vocabularies, and as more electronic prescriptions are written,
the need to use claims data (where NDCs are most commonly
found) is lessened.9.3. Problem list terminology challenges
While the largest terminological issue we encountered in the
development of this prototype was related to drugs, problem list
terminology also provided some interesting challenges. Perhaps,
the most widely used system for encoding problems is ICD-9.
While this works to simplify billing, it is frequently the case that
the level of detail required for describing a patient’s problem for
clinical purposes differs from the level of detail required for
describing the same problem for billing purposes.
An initial version of the prototype system used ICD-9 codes be-
cause of their wide use and availability and because the NHIN pro-
totype used generally provides problem information in ICD-9
format. However, ongoing use of the prototype quickly showed
that ICD-9 codes were inadequate for describing many common
clinical problems, an issue which has been previously described
in the literature [68]. As such, we converted the problem list for-
mat for our prototype to SNOMED. Because SNOMED is a very large
terminology designed for a variety of clinical purposes, we em-
ployed a subset of the SNOMED terminology designed for problem
lists and developed by Kaiser Permanente and the Department of
Veterans Affairs. This subset is frequently used for problem lists
and is available either directly from the Veterans Affairs adminis-
tration or via the UMLS. In addition to more clinically relevant
problems, using SNOMED provides several signiﬁcant advantages
for decision support developers. SNOMED provides a rich semantic
structure and hierarchy of concepts so that it is possible to develop
rules that correctly handle generality. For example, SNOMED de-
ﬁnes a heart disease concept so it is possible to develop a rule that
says ‘‘patients with a history of heart disease should receive an
inﬂuenza vaccination.” Then, even if the patient’s problem list does
not contain the concept ‘‘heart disease”, but contains a sub-concept
such as ‘‘dilated cardiomyopathy” a rule engine that exploits SNO-
MED’s concept network can correctly reason that the inﬂuenza
vaccination rule still applies. While ICD-9 has its own concept hier-
archy, it is much less rich than SNOMED’s and is designed for bill-
ing rather than clinical purposes.
9.4. Economics and business models
At present, a number of restraints hinder the development of a
full and robust market for clinical decision support. For most pur-
chasers of clinical systems, such as electronic health records or
computerized physician order entry systems, the easiest option
for purchasing decision support content is to purchase it directly
from their clinical system vendor. These vendors often have part-
nerships with preferred content providers. This creates a signiﬁ-
cant degree of vendor lock-in because if that vendor’s customer
wishes to employ a non-preferred clinical decision support system,
they may be forced to develop costly interfaces. With open stan-
dards-based systems, such as SANDS, purchasers of clinical infor-
mation systems can instead adopt a building block model—
purchasing the clinical information system of their choice and then
choosing, application by application, the decision support systems
that best meet their needs.
We anticipate that with an architecture such as this we
would see a variety of business models for providing clinical
decision support content. In some ways, one can conceptualize
this architecture as being a sort of Internet for clinical decision
support. Just as the Internet has a rich market of content suppli-
ers ranging from paid providers of content to open source con-
tent, and even community edited content such as Wikipedia,
so too could all of these models be supported in this decision
support architecture. In many cases, we might expect that users
would prefer to purchase decision support content from estab-
lished vendors. However, it is also easy to imagine cases where
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pic might provide free decision support content. For example,
many medical specialty societies have expressed interest in pro-
viding electronic forms of the paper guidelines they currently
publish. An architecture such as this one would provide an open
and high-leverage way for specialty societies to increase the
adoption and use of such guidelines. One might further imagine
other stakeholders that would be interested in providing clinical
decision support systems. Consider, for example, the syndromic
surveillance and disease reporting system described earlier in
this paper. At present, public health departments spend large
amounts of money developing disease tracking systems and pub-
licizing them to encourage providers to report diagnoses of
reportable diseases. Some of these resources could instead be
dedicated to providing electronic decision support systems such
as the one developed here which would automate portions of
this process. Then, users of clinical systems who wish to auto-
matically report reportable diseases could simply add this deci-
sion support service to their clinical system. Both the provider
of a decision support system (in this case, the public health
department) and the consumer of the service (in this case, a care
provider) have strong incentives to cooperate around such a free
decision support service.
Because of the exciting potential for a variety of business mod-
els to ﬂourish we were careful to avoid being prescriptive about
the business model or economic relationship between service pro-
viders and service consumers. Instead, any provider or consumer
who can communicate according to the decision support standard
deﬁned in this paper would be welcome to participate. The busi-
ness relationship, if any, between the provider and the consumer
would be determined by the two parties.
One concern that arises when there is a business relationship
between a provider of clinical information and a provider of clin-
ical care is the issue of liability. In the 1980s, there was much
debate in the ﬁeld of informatics about whether clinical systems
and clinical decision support systems should be regulated as
medical devices, and whether there should be liability on the
part of system providers for errors or omissions in their content
or systems [69]. While this question is still not settled law, the
strong direction is that decision support content should be regu-
lated and held liable using the same principles that apply to
medical textbooks (which are, after all, a paper form of clinical
decision support). In this paradigm, so long as there is a human
intermediary between the device or system and the patient, that
intermediary is the responsible provider, and there is no conse-
quential liability for the system provider. That said, content pro-
viders and purchasers could certainly contract for additional
indemniﬁcation—for example, a drug information provider might
guarantee that their system will not miss any documented high
severity drug interactions. In the reverse, a free content provider
might require that hospitals which employ its service indemnify
the content provider against liability for content errors. This is a
form of insurance, and it is possible that it, too, might become a
basis of competition in a marketplace for clinical decision sup-
port. All things being equal, a decision support service which of-
fered indemnity would be more attractive than one that did not.
If, on the other hand, there was an additional cost for this
indemnity, providers and purchasers would have to conduct
internal cost beneﬁt analyses to determine the cost and value
of such indemnity protection. The issue of liability and indemni-
ﬁcation is challenging, and it is unlikely to be resolved until a
body of case law is established in the courts, or until the legal
situation is clariﬁed through regulation or legislation. It is worth
noting that this issue affects all decision support involving a
third-party content provider, regardless of the technical architec-
ture employed.9.5. Organizational issues and implications
In addition to the economic implications, there are also organi-
zational implications to consider with any clinical decision support
or clinical system, and this architecture is no different. The best
evidence suggests that a phased approach to the implementation
of any new clinical system or clinical decision support intervention
is most likely to be successful [70]. However, phased implementa-
tions are often very difﬁcult to execute when using a monolithic
system because the parts of the system often fail to function unless
integrated into a whole. The SANDS architecture is inherently de-
signed for extreme modularity. It would be conceivable that one
might initially deploy a clinical system with no decision support
turned on. After the issues surrounding the deployment settle
out, the implementer could then slowly turn on clinical decision
support modules as user experience and organizational priorities
dictate.
Moreover, an architecture such as SANDS allows an organiza-
tion to be more responsive to user feedback. For example, if users
report that they are extremely satisﬁed with the user interface of a
new clinical system, but very dissatisﬁed with the accuracy of the
drug interaction alerts that the system produces, it would be easy
to keep the same clinical system, but substitute a different drug
interaction service. It would even be possible to conduct trials of
various decision support services to determine which service pro-
vides the greatest accuracy and user satisfaction. Modularity
would be much more difﬁcult to achieve with other decision sup-
port architectures.10. Conclusion
SANDS has several signiﬁcant advantages over other architec-
tures for clinical decision support, the most salient advantages
include:
 Modularity: An SOA provides more modularity than other archi-
tectures, allowing for work to be distributed. With a fully real-
ized architecture medical specialty societies might, for
example, each produce guidelines in their area of expertise,
but make them available for consumption by anyone.
 A market for decision support: Commercial services can play a
role in an SOA, by providing services and content for which they
charge a fee.
 Trialability/switchability: An SOA reduces the cost and risk of try-
ing new decision support systems: a hospital or healthcare pro-
vider could always connect to a new decision support service
and try it out, but could freely disconnect if it did not perform
as desired.
 Maximal expressiveness: An SOA speciﬁes the interfaces a service
must provide, but imposes no restrictions on its
implementation.
 Alignment with interoperability: Finally, the key advantage of this
architecture is its potential to ‘‘unstick” progress on decision
support, by uniting the direction of clinical decision support
with promising near-term efforts to improve interoperability.
11. Conﬂicts of interest
It is our hope that the SANDS architecture will be an enabling
step towards wider adoption of clinical decision support. We are
aware that there have been intellectual-property-related concerns
surrounding the adoption of service-oriented architectures for
decision support [71]. In recognition of these concerns, we are
making the full speciﬁcations of the architecture freely available,
980 A. Wright, D.F. Sittig / Journal of Biomedical Informatics 41 (2008) 962–981and are simultaneously releasing a collection of open source tools,
libraries and reference implementations to guide those who wish
to implement SANDS. While we foresee a wide variety of business
models developing around SANDS, we believe that no single person
or entity should try to own, control or restrict access to such a net-
work, just as no entity owns or controls the Internet. To that end,
we pledge not to seek any exclusionary intellectual property rights
to SANDS, such as patents, which would allow us or others to exert
such control. Instead, we will work through open standards pro-
cesses to ensure that anyone who wishes to access SANDS, either
as a provider or consumer of decision support services, can do so
freely.
A portion of the architecture described here is based on work
done by the Markle Foundation. Subsequent to completing this re-
search, Author Wright was retained by the Markle Foundation in a
consulting role on issues relating to Population Health.
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